Cytokinetics
CYTK
$35.90
Share price
-1.99%
Change (1 day)
-39.25%
Change (1 year)
Categories
Cytokinetics (CYTK) - Net assets
Net assets on the balance sheet as of March 2025 : -$0.27 Billion USD
According to Cytokinetics
's latest financial reports the company has -$0.27 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Cytokinetics - Net assets on balance sheet (from 2003 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $-$0.14 Billion | -64.96% |
| 2023-12-31 | $-$0.39 Billion | 258.04% |
| 2022-12-31 | $-$0.11 Billion | -144.25% |
| 2021-12-31 | $$0.24 B | 115.08% |
| 2020-12-31 | $$0.11 B | -1136.69% |
| 2019-12-31 | $-$10.94 Million | -142.17% |
| 2018-12-31 | $$25.93 M | -76.39% |
| 2017-12-31 | $$0.10 B | 16.41% |
| 2016-12-31 | $$94.36 M | 37.57% |
| 2015-12-31 | $$68.59 M | -25.5% |
| 2014-12-31 | $$92.06 M | 69.1% |
| 2013-12-31 | $$54.44 M | -22.32% |
| 2012-12-31 | $$70.08 M | 45.47% |
| 2011-12-31 | $$48.17 M | -31.68% |
| 2010-12-31 | $$70.51 M | -30.48% |
| 2009-12-31 | $$0.10 B | 103.81% |
| 2008-12-31 | $$49.76 M | -50.19% |
| 2007-12-31 | $$99.91 M | -6.02% |
| 2006-12-31 | $$0.10 B | 44.52% |
| 2005-12-31 | $$73.56 M | -31.61% |
| 2004-12-31 | $$0.10 B | -216.87% |
| 2003-12-31 | $-$92.04 Million | 51.9% |
| 2002-12-31 | $-$60.59 Million | 62.21% |
| 2001-12-31 | $-$37.36 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $0.79 B | -398.61% | 🇺🇸 USA |
 Trevena TRVN | -$23.31 Million | -91.25% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$0.19 Billion | -30.27% | 🇺🇸 USA |
 Amgen AMGN | $6.20 B | -2,429.84% | 🇺🇸 USA |
 Array Technologies ARRY | $0.32 B | -221.47% | 🇺🇸 USA |